# Neurology Consultation

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Julius Caesar (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-AC001-SYN
- Date: 2026-08-18
- Fictional facility: St. Posthumous Health Center
- Fictional author: Valeria Lindqvist-Adeyemi, MD
- Calendar frame: modern shifted

- Requested by: Lucius Fairbanks-Okonkwo, MD

## Reason for consultation

Three spells of loss of awareness in eighteen months in a 54-year-old man, the latest with stiffening and jerking of both arms, a bitten tongue, and twenty minutes of confusion. Please advise whether these are seizures, convulsive syncope, or transient ischemic attacks, interpret the EEG and MRI, and advise on treatment, stroke prevention, and driving. **S**

## History

Julius Caesar is seen at the request of Dr. Fairbanks-Okonkwo, two weeks after a witnessed collapse. I took a fuller history from him and from the member of his staff who saw the latest spell. All three spells began with the same rising feeling in the upper abdomen, sometimes with a sense that things were strange or familiar; in two he stared and smacked his lips for a minute or so without responding; in the latest the arms then stiffened and jerked for about a minute. Each was followed by confusion of many minutes, and the latest by a bitten tongue and sore shoulders. None began with pallor, sweating, or greying vision, and none followed pain or a sudden change of posture; he had been standing for a long time in heat at the last. He has never had a sudden weakness, numbness, loss of speech, or loss of vision lasting minutes. He wakes every few weeks from vivid, frightening dreams, confused for a minute or two. He has occasional mild headaches. No head injury, meningitis, or febrile seizures in childhood that he knows of. He has had no spell since the first visit. He does not drive at present. **S**

## Examination

| System | Finding |
|---|---|
| General | Alert and composed; blood pressure 140/88 mmHg |
| Cognition and language | Oriented; fluent speech with normal naming, repetition, and comprehension |
| Cranial nerves | Visual fields full to confrontation; normal eye movements; face symmetric |
| Motor and sensory | No pronator drift; normal strength, tone, reflexes, and sensation |
| Coordination and gait | Normal finger-nose testing, gait, and tandem walk |

BP 140/88 mmHg; pulse 68 bpm; respirations 14/min; temperature 36.6 °C; oxygen saturation 98% on room air; weight 75.8 kg; BMI 22.9 kg/m². All vital signs are synthetic.

## Data reviewed

The emergency department notes (normal CT of the head, glucose, and sodium); the intake ECG; the 14-day ambulatory ECG (sinus rhythm throughout, a marked event of light-headedness on standing in sinus rhythm); the EEG with sleep (intermittent left temporal sharp waves in drowsiness and light sleep, normal background); MRI of the brain (no acute infarct; a chronic 1.5 cm cortical and subcortical infarct with gliosis in the left posterior temporal lobe; moderate white matter hyperintensities; no microbleeds, mass, vascular malformation, cyst, or calcification; normal hippocampi); CT angiography of the head and neck (calcified left carotid bifurcation plaque under 30 percent; no other stenosis, dissection, aneurysm, or malformation); the echocardiogram (ejection fraction 60 percent, mild concentric hypertrophy, normal left atrium, no thrombus or shunt); intake laboratory tests; and today's potassium 4.5 mmol/L and creatinine 1.02 mg/dL. Sodium: 140 mmol/L; Potassium: 4.5 mmol/L; Creatinine: 1.02 mg/dL; eGFR: 86 mL/min/1.73 m². All results are synthetic.

## Assessment

1. **Focal epilepsy with a structural vascular cause** (G40.209). These are seizures. The stereotyped rising epigastric aura, staring with oral automatisms, and prolonged confusion are typical of focal seizures from the temporal lobe, and the latest evolved to a bilateral tonic-clonic seizure. Convulsive syncope is brief, follows a prodrome of pallor and greying vision, and recovers within a minute or two; his rhythm, echocardiogram, and orthostatic readings are normal. Transient ischemic attacks cause loss of function, not loss of awareness with automatisms. ILAE 2017: focal impaired-awareness seizures with automatisms and a focal to bilateral tonic-clonic seizure; structural (vascular) cause. Three unprovoked seizures meet the ILAE definition of epilepsy; the brain lesion and the epileptiform EEG both raise the risk of recurrence. The vivid dreams with confused awakening may be nocturnal seizures and should go in the seizure diary. **S**
2. **Chronic left posterior temporal cortical infarct** (I69.398). The left temporal infarct matches the EEG and is the likely seizure focus. It was never recognized as a stroke, but because it now causes epilepsy I would not treat it as a silent infarct; I advise secondary stroke prevention as after an ischemic stroke of undetermined cause. No source of embolism so far; prolonged monitoring is still needed for atrial fibrillation. Moderate white matter disease fits long-standing untreated hypertension. **S**
3. **Hypertension** (I10). The main modifiable cause of his small-vessel disease; the target is below 130/80 mmHg. **S**

## Recommendations

1. Start levetiracetam 500 mg twice daily today: effective for focal seizures, no titration needed, and no interactions with his other medicines. Warn about irritability and low mood, check mood at four weeks, and keep a seizure diary. Lamotrigine is the alternative if mood side effects occur.
2. Aspirin 81 mg daily and atorvastatin 80 mg at bedtime, with a lipid panel at 4 to 12 weeks and an LDL target below 70 mg/dL; dual antiplatelet therapy is not indicated for an old infarct.
3. Blood pressure below 130/80 mmHg: continue lisinopril and add a second medicine, such as amlodipine, if he stays above target.
4. A second ambulatory monitor for at least four more weeks, for more than 30 days in all, to exclude atrial fibrillation before settling on aspirin alone.
5. Screen for sleep apnea (STOP-Bang, with a home sleep test if intermediate or high), check mood with the PHQ-9, and screen cognition with the MoCA in the first months.
6. No driving until he has been seizure-free for the period state law requires (six months in this state) and I have cleared him; no swimming or riding alone, no climbing to heights, showers rather than baths, regular sleep, and a written seizure action plan for his staff, with emergency services called for a seizure lasting more than five minutes or a second seizure.
7. Neurology review at six months, sooner for any seizure.

## Strengths and supports

- Engagement in care and meaningful activity **S**

## Communication

Discussed with Dr. Fairbanks-Okonkwo the same day. Julius Caesar understands the diagnosis, agrees to start levetiracetam, aspirin, and atorvastatin today, and accepts the driving restriction, though it frustrates him. **S**

## Follow-up

Primary care continues with Dr. Fairbanks-Okonkwo. Neurology review at six months, sooner for any seizure, a confused awakening that is clearly a seizure, or side effects. **S**

## Guideline basis

- Evidence-based guideline: Management of an unprovoked first seizure in adults: Report of the Guideline Development Subcommittee of the American Academy of Neurology and the American Epilepsy Society (2015), American Academy of Neurology and American Epilepsy Society (Neurology)
- Operational classification of seizure types by the International League Against Epilepsy: Position Paper of the ILAE Commission for Classification and Terminology (2017), International League Against Epilepsy (Epilepsia)
- ILAE classification of the epilepsies: Position paper of the ILAE Commission for Classification and Terminology (2017), International League Against Epilepsy (Epilepsia)
- ILAE official report: a practical clinical definition of epilepsy (2014), International League Against Epilepsy (Epilepsia)
- Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new-onset epilepsy (2018), American Academy of Neurology and American Epilepsy Society (Neurology)
- 2017 ACC/AHA/HRS Guideline for the Evaluation and Management of Patients With Syncope (2017), American College of Cardiology, American Heart Association, and Heart Rhythm Society (Journal of the American College of Cardiology)
- 2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack (2021), American Heart Association and American Stroke Association (Stroke)
- Prevention of Stroke in Patients With Silent Cerebrovascular Disease: A Scientific Statement for Healthcare Professionals From the American Heart Association/American Stroke Association (2017), American Heart Association and American Stroke Association (Stroke)
